Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Feb 26, 2016; 8(2): 120-131
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.120
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.120
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background
Giulia Ganzetti, Anna Campanati, Elisa Molinelli, Annamaria Offidani, Dermatological Unit, Department of Clinical and Molecular Sciences, Polytehnic Marche University, 60126 Ancona, Italy
Author contributions: Ganzetti G, Campanati A and Molinelli E wrote the paper; Offidani A supervised the work.
Conflict-of-interest statement: All authors declare no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Giulia Ganzetti, MD, PhD, Dermatological Unit, Department of Clinical and Molecular Sciences, Polytehnic Marche University, Via Conca, 71, 60126 Ancona, Italy. giulia.ganzetti@alice.it
Telephone: +39-71-5965686 Fax: +39-71-5963446
Received: April 28, 2015
Peer-review started: May 6, 2015
First decision: July 22, 2015
Revised: October 8, 2015
Accepted: December 17, 2015
Article in press: December 18, 2015
Published online: February 26, 2016
Processing time: 299 Days and 14.6 Hours
Peer-review started: May 6, 2015
First decision: July 22, 2015
Revised: October 8, 2015
Accepted: December 17, 2015
Article in press: December 18, 2015
Published online: February 26, 2016
Processing time: 299 Days and 14.6 Hours
Core Tip
Core tip: The review focuses on recent scientific data regarding the multiple physio-pathogenetic aspects of the possible link between psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease. The multidisciplinary approach to psoriatic patients appears mandatory to treat concomitant psoriasis-related comorbidity, and the risk/benefit of both biologic and non-biologic therapies should be evaluated.